# Effect of Denosumab in Erosion Healing in RA

> **NCT03239080** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 110 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Denosumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03239080
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-19
- **Primary completion:** 2020-05-24
- **Final completion:** 2020-05-24
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239080, "Effect of Denosumab in Erosion Healing in RA". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03239080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*